Literature DB >> 24331775

Effects of body weight reduction on cardio-ankle vascular index (CAVI).

Daiji Nagayama1, Kei Endo1, Masahiro Ohira1, Takashi Yamaguchi1, Noriko Ban1, Hidetoshi Kawana1, Ayako Nagumo1, Atsuhito Saiki2, Tomokazu Oyama1, Yoh Miyashita1, Kohji Shirai3.   

Abstract

OBJECTIVE: Obesity is associated with type 2 diabetes, dyslipidemia and hypertension, contributing to atherogenesis. Weight reduction is the fundamental therapy for obesity. Recently, a novel arterial stiffness parameter called cardio-ankle vascular index (CAVI) has been developed. We hypothesized that CAVI may be a candidate marker of increased vascular stiffness in obese patients. The aim of this study is to investigate the effect of weight reduction on CAVI. SUBJECTS AND METHODS: Using CAVI as an indicator, we assessed the changes in arterial stiffness in 47 obese Japanese subjects (aged 46 ± 13 years) who underwent a 12-week weight reduction program consisting of a calorie restriction diet (20-25 kcal/day) and exercise therapy. Visceral fat area (VFA) was evaluated by CT.
RESULTS: At baseline, CAVI correlated positively with age (r = 0.70), blood pressure (r = 0.23), VFA (r = 0.26) and HbA1c (r = 0.39). After 12 weeks of weight reduction, mean BMI decreased from 33.3 ± 7.5 to 30.7 ± 6.4 kg/m(2) (p < 0.0001), and mean CAVI decreased from 8.3 to 7.9 (p < 0.01). The change in VFA correlated positively with change in CAVI in subjects with decrease in CAVI (r = 0.47). Furthermore, change in VFA was a significant independent predictor for change in CAVI. No significant correlation was observed between change in CAVI and clinical variables such as BMI, HbA1c and lipids.
CONCLUSION: This study demonstrated that CAVI decreased after weight reduction, and was associated with a decrease in VFA. CAVI reduction maybe a marker of improved vascular stiffness after weight reduction in subjects with visceral adiposity. Â
© 2013 Asian Oceanian Association for the Study of Obesity . Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24331775     DOI: 10.1016/j.orcp.2011.08.154

Source DB:  PubMed          Journal:  Obes Res Clin Pract        ISSN: 1871-403X            Impact factor:   2.288


  23 in total

1.  Relation of Maximum Lifetime Body Mass Index with Age at Hemodialysis Initiation and Vascular Complications in Japan.

Authors:  Akira Onozaki; Daiji Nagayama; Nakanobu Azuma; Keita Sugai; Etsuko Shitara; Takehiko Sakai; Motoyuki Masai; Kohji Shirai; Ichiro Tatsuno
Journal:  Obes Facts       Date:  2021-08-13       Impact factor: 3.942

2.  Issue of Waist Circumference for the Diagnosis of Metabolic Syndrome Regarding Arterial Stiffness: Possible Utility of a Body Shape Index in Middle-Aged Nonobese Japanese Urban Residents Receiving Health Screening.

Authors:  Daiji Nagayama; Yasuhiro Watanabe; Takashi Yamaguchi; Kenji Suzuki; Atsuhito Saiki; Kentaro Fujishiro; Kohji Shirai
Journal:  Obes Facts       Date:  2022-01-10       Impact factor: 4.807

Review 3.  Therapeutic modification of arterial stiffness: An update and comprehensive review.

Authors:  Ching-Fen Wu; Pang-Yen Liu; Tsung-Jui Wu; Yuan Hung; Shih-Ping Yang; Gen-Min Lin
Journal:  World J Cardiol       Date:  2015-11-26

Review 4.  The Role of Monitoring Arterial Stiffness with Cardio-Ankle Vascular Index in the Control of Lifestyle-Related Diseases.

Authors:  Kohji Shirai; Atsuhito Saiki; Daiji Nagayama; Ichiro Tatsuno; Kazuhiro Shimizu; Mao Takahashi
Journal:  Pulse (Basel)       Date:  2015-06-20

Review 5.  Evaluation of blood pressure control using a new arterial stiffness parameter, cardio-ankle vascular index (CAVI).

Authors:  Kohji Shirai; Junji Utino; Atsuhito Saiki; Kei Endo; Masahiro Ohira; Daiji Nagayama; Ichiro Tatsuno; Kazuhiro Shimizu; Mao Takahashi; Akira Takahara
Journal:  Curr Hypertens Rev       Date:  2013-02

6.  Clinical Applications Measuring Arterial Stiffness: An Expert Consensus for the Application of Cardio-Ankle Vascular Index.

Authors:  Matthew J Budoff; Bruce Alpert; Julio A Chirinos; Bo Fernhall; Naomi Hamburg; Kazuomi Kario; Iftikhar Kullo; Kunihiro Matsushita; Toru Miyoshi; Hirofumi Tanaka; Ray Townsend; Paul Valensi
Journal:  Am J Hypertens       Date:  2022-05-10       Impact factor: 3.080

7.  Cardio-ankle vascular index is associated with cardiovascular target organ damage and vascular structure and function in patients with diabetes or metabolic syndrome, LOD-DIABETES study: a case series report.

Authors:  Manuel Ángel Gómez-Marcos; José Ignacio Recio-Rodríguez; María Carmen Patino-Alonso; Cristina Agudo-Conde; Leticia Gómez-Sánchez; Marta Gomez-Sanchez; Emiliano Rodríguez-Sanchez; Jose Angel Maderuelo-Fernandez; Luís García-Ortiz
Journal:  Cardiovasc Diabetol       Date:  2015-01-16       Impact factor: 9.951

8.  Effect of nitroglycerin administration on cardio-ankle vascular index.

Authors:  Kazuhiro Shimizu; Tomoyuki Yamamoto; Mao Takahashi; Shuji Sato; Hirofumi Noike; Kohji Shirai
Journal:  Vasc Health Risk Manag       Date:  2016-08-03

9.  Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin.

Authors:  Masahiro Ohira; Takashi Yamaguchi; Atsuhito Saiki; Noriko Ban; Hidetoshi Kawana; Ayako Nagumo; Takeyoshi Murano; Kohji Shirai; Ichiro Tatsuno
Journal:  Diabetes Metab Syndr Obes       Date:  2014-07-17       Impact factor: 3.168

10.  Arterial stiffness, as monitored by cardio-ankle vascular index, is affected by obstructive sleep apnea, blood glucose control, and body weight - a case with 8 years follow up.

Authors:  Kazuhiro Shimizu; Tomoyuki Yamamoto; Kohji Shirai
Journal:  Int Med Case Rep J       Date:  2016-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.